Related references
Note: Only part of the references are listed.Multi-marker profiling of extracellular vesicles using streaming current and sequential electrostatic labeling
Siddharth S. Sahu et al.
BIOSENSORS & BIOELECTRONICS (2023)
The potential use of mesenchymal stem cells-derived exosomes as microRNAs delivery systems in different diseases
Elham Oveili et al.
CELL COMMUNICATION AND SIGNALING (2023)
Mesenchymal stem cell-derived exosomes as new tools for delivery of miRNAs in the treatment of cancer
Aysegul Dalmizrak et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)
Exosomes derived from miR-188-3p-modified adipose-derived mesenchymal stem cells protect Parkinson's disease
Qiang Li et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
Oligonucleotides as therapeutic tools for brain disorders: Focus on major depressive disorder and Parkinson's disease
Analia Bortolozzi et al.
PHARMACOLOGY & THERAPEUTICS (2021)
MicroRNAs and exosomes: Small molecules with big actions in multiple myeloma pathogenesis
Mohammad H. Pourhanifeh et al.
IUBMB LIFE (2020)
The Promise and Challenges of Developing miRNA-Based Therapeutics for Parkinson's Disease
Simoneide S. Titze-de-Almeida et al.
CELLS (2020)
Designer Exosomes: A New Platform for Biotechnology Therapeutics
Davod Jafari et al.
BIODRUGS (2020)
Bone marrow-derived mesenchymal stem cells improve cognitive impairment in an Alzheimer's disease model by increasing the expression of microRNA-146a in hippocampus
Masako Nakano et al.
SCIENTIFIC REPORTS (2020)
Exosome: A Review of Its Classification, Isolation Techniques, Storage, Diagnostic and Targeted Therapy Applications
Yi Zhang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
PINK1/PARKIN signalling in neurodegeneration and neuroinflammation
Peter M. J. Quinn et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Mesenchymal Stem Cells-derived Exosomes: A New Possible Therapeutic Strategy for Parkinson's Disease?
Helena Vilaca-Faria et al.
CELLS (2019)
Role of DJ-1 in the mechanism of pathogenesis of Parkinson's disease
Ludmila P. Dolgacheva et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2019)
Advances in Technologies for Purification and Enrichment of Extracellular Vesicles
Pan Zhang et al.
SLAS TECHNOLOGY (2019)
Systemic Exosomal Delivery of shRNA Minicircles Prevents Parkinsonian Pathology
Maria Izco et al.
MOLECULAR THERAPY (2019)
Serum secreted miR-137-containing exosomes affects oxidative stress of neurons by regulating OXR1 in Parkinson's disease
Yan Jiang et al.
BRAIN RESEARCH (2019)
miR-124 and Parkinson's disease: A biomarker with therapeutic potential
Efthalia Angelopoulou et al.
PHARMACOLOGICAL RESEARCH (2019)
Parkinson's Disease and Parkinsonism
Michael T. Hayes
AMERICAN JOURNAL OF MEDICINE (2019)
Design strategies and application progress of therapeutic exosomes
Chunying Liu et al.
THERANOSTICS (2019)
Molecular aspects of diabetes mellitus: Resistin, microRNA, and exosome
Mohammad Javad Saeedi Borujeni et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Genetics of Parkinson's disease and related disorders
Pei-Lan Zhang et al.
JOURNAL OF MEDICAL GENETICS (2018)
Integrated Analysis of Exosomal Protein Biomarkers on Alternating Current Electrokinetic Chips Enables Rapid Detection of Pancreatic Cancer in Patient Blood
Jean M. Lewis et al.
ACS NANO (2018)
A Novel Strategy to Increase the Yield of Exosomes (Extracellular Vesicles) for an Expansion of Basic Research
Sherif E. Emam et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2018)
Simultaneous isolation and preconcentration of exosomes by ion concentration polarization
Steven Marczak et al.
ELECTROPHORESIS (2018)
Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation
Haiying Zhang et al.
NATURE CELL BIOLOGY (2018)
Environmental neurotoxicant manganese regulates exosome-mediated extracellular miRNAs in cell culture model of Parkinson's disease: Relevance to α-synuclein misfolding in metal neurotoxicity
Dilshan S. Harischandra et al.
NEUROTOXICOLOGY (2018)
Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson's disease treatment
Ryosuke Kojima et al.
NATURE COMMUNICATIONS (2018)
Recent Advances: Decoding Alzheimer's Disease With Stem Cells
Yi Fang et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease
Geraldine Gelders et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Alpha-Synuclein: From Early Synaptic Dysfunction to Neurodegeneration
Veronica Ghiglieri et al.
FRONTIERS IN NEUROLOGY (2018)
Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's disease
Mengke Qu et al.
JOURNAL OF CONTROLLED RELEASE (2018)
MicroRNA-21 Overexpression Promotes the Neuroprotective Efficacy of Mesenchymal Stem Cells for Treatment of Intracerebral Hemorrhage
Heyu Zhang et al.
FRONTIERS IN NEUROLOGY (2018)
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
Clotilde Thery et al.
JOURNAL OF EXTRACELLULAR VESICLES (2018)
Engineering mesenchymal stem cells to improve their exosome efficacy and yield for cell-free therapy
Jennifer Phan et al.
JOURNAL OF EXTRACELLULAR VESICLES (2018)
Novel Compound Heterozygous Synaptojanin-1 Mutation Causes L-Dopa-Responsive Dystonia-Parkinsonism Syndrome
Marc-Alexander Rauschendorf et al.
MOVEMENT DISORDERS (2017)
Diagnostic and Therapeutic Potential of Exosomes in Cancer: The Beginning of a New Tale?
Hamed Mirzaei et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
Loss of MicroRNA-7 Regulation Leads to α-Synuclein Accumulation and Dopaminergic Neuronal Loss In Vivo
Kirsty J. McMillan et al.
MOLECULAR THERAPY (2017)
High-purity capture and release of circulating exosomes using an exosome-specific dual-patterned immunofiltration (ExoDIF) device
Yoon-Tae Kang et al.
NANOSCALE (2017)
α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies
Yvette C. Wong et al.
NATURE MEDICINE (2017)
TMEM230 mutation analysis in Parkinson's disease in a Chinese population
Weiqian Yan et al.
NEUROBIOLOGY OF AGING (2017)
MicroRNA-4639 Is a Regulator of DJ-1 Expression and a Potential Early Diagnostic Marker for Parkinson's Disease
Yimeng Chen et al.
FRONTIERS IN AGING NEUROSCIENCE (2017)
The Exosome Total Isolation Chip
Fei Liu et al.
ACS NANO (2017)
Chemically Edited Exosomes with Dual Ligand Purified by Microfluidic Device for Active Targeted Drug Delivery to Tumor Cells
Jie Wang et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
High miR-124-3p expression identifies smoking individuals susceptible to atherosclerosis
Maurice W. J. de Ronde et al.
ATHEROSCLEROSIS (2017)
Exodisc for Rapid, Size-Selective, and Efficient Isolation and Analysis of Nanoscale Extracellular Vesicles from Biological Samples
Hyun-Kyung Woo et al.
ACS NANO (2017)
Regulation of Histone Acetylation by Autophagy in Parkinson Disease
Goonho Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Good things come in small packages: Overcoming challenges to harness extracellular vesicles for therapeutic delivery
Dominique Ingato et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Evidence of mutations in RIC3 acetylcholine receptor chaperone as a novel cause of autosomal-dominant Parkinson's disease with non-motor phenotypes
Sumedha Sudhaman et al.
JOURNAL OF MEDICAL GENETICS (2016)
Nanoscale lateral displacement arrays for the separation of exosomes and colloids down to 20 nm
Benjamin H. Wunsch et al.
NATURE NANOTECHNOLOGY (2016)
Identification of a novel homozygous mutation Arg459Pro in SYNJ1 gene of an Indian family with autosomal recessive juvenile Parkinsonism
Laxmi Kirola et al.
PARKINSONISM & RELATED DISORDERS (2016)
Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes
Joanna Kowal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges
Dinh Ha et al.
ACTA PHARMACEUTICA SINICA B (2016)
Nanoparticle analysis sheds budding insights into genetic drivers of extracellular vesicle biogenesis
Stephanie N. Hurwitz et al.
JOURNAL OF EXTRACELLULAR VESICLES (2016)
Extracellular Vesicles: Composition, Biological Relevance, and Methods of Study
Mikolaj P. Zaborowski et al.
BIOSCIENCE (2015)
Exosomes as drug delivery vehicles for Parkinson's disease therapy
Matthew J. Haney et al.
JOURNAL OF CONTROLLED RELEASE (2015)
CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study
Manabu Funayama et al.
LANCET NEUROLOGY (2015)
DNA methylation levels of α-synuclein intron 1 in the aging brain
Laura de Boni et al.
NEUROBIOLOGY OF AGING (2015)
Stem Cell-Based Tissue Replacement After Stroke Factual Necessity or Notorious Fiction?
Miroslaw Janowski et al.
STROKE (2015)
Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting
Oscar P. B. Wiklander et al.
JOURNAL OF EXTRACELLULAR VESICLES (2015)
Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease?
Walter J. Schulz-Schaeffer
BIOMOLECULES (2015)
Identification of distinct circulating exosomes in Parkinson's disease
Paul R. Tomlinson et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
DNAJC13 mutations in Parkinson disease
Carles Vilarino-Gueell et al.
HUMAN MOLECULAR GENETICS (2014)
Extracellular vesicles as drug delivery systems: Lessons from the liposome field
Roy van der Meel et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Systemic Exosomal siRNA Delivery Reduced Alpha-Synuclein Aggregates in Brains of Transgenic Mice
J. Mark Cooper et al.
MOVEMENT DISORDERS (2014)
DOWNREGULATION OF MIR-124 IN MPTP-TREATED MOUSE MODEL OF PARKINSON'S DISEASE AND MPP IODIDE-TREATED MN9D CELLS MODULATES THE EXPRESSION OF THE CALPAIN/CDK5 PATHWAY PROTEINS
N. Kanagaraj et al.
NEUROSCIENCE (2014)
Methylation of α-synuclein and leucine-rich repeat kinase 2 in leukocyte DNA of Parkinson's disease patients
Yu-yan Tan et al.
PARKINSONISM & RELATED DISORDERS (2014)
miR-7 and miR-153 protect neurons against MPP+-induced cell death via upregulation of mTOR pathway
Apostolia Fragkouli et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
G51D α-Synuclein mutation causes a novel Parkinsonian-pyramidal syndrome
Suzanne Lesage et al.
ANNALS OF NEUROLOGY (2013)
Schwann Cell-Derived Exosomes Enhance Axonal Regeneration in the Peripheral Nervous System
Maria Alejandra Lopez-Verrilli et al.
GLIA (2013)
The many faces of alpha-synuclein: from structure and toxicity to therapeutic target
Hilal A. Lashuel et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Gene-environment interactions in Parkinson's disease: Specific evidence in humans and mammalian models
Jason R. Cannon et al.
NEUROBIOLOGY OF DISEASE (2013)
The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles
Takeshi Katsuda et al.
PROTEOMICS (2013)
MiR-133b Promotes Neural Plasticity and Functional Recovery After Treatment of Stroke with Multipotent Mesenchymal Stromal Cells in Rats Via Transfer of Exosome-Enriched Extracellular Particles
Hongqi Xin et al.
STEM CELLS (2013)
Drug transport across the blood-brain barrier
William M. Pardridge
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
Intercellular communication: diverse structures for exchange of genetic information
Maria Mittelbrunn et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
MicroRNAs in Parkinson's disease
M. Maral Mouradian
NEUROBIOLOGY OF DISEASE (2012)
Exosome-Mediated Transfer of miR-133b from Multipotent Mesenchymal Stromal Cells to Neural Cells Contributes to Neurite Outgrowth
Hongqi Xin et al.
STEM CELLS (2012)
Beyond α-synuclein transfer: pathology propagation in Parkinson's disease
Christian Hansen et al.
TRENDS IN MOLECULAR MEDICINE (2012)
Role of exosomes/microvesicles in the nervous system and use in emerging therapies
Charles Pin-Kuang Lai et al.
FRONTIERS IN PHYSIOLOGY (2012)
Drug therapy in patients with Parkinson's disease
Thomas Mueller
TRANSLATIONAL NEURODEGENERATION (2012)
Diverse subpopulations of vesicles secreted by different intracellular mechanisms are present in exosome preparations obtained by differential ultracentrifugation
Angelique Bobrie et al.
JOURNAL OF EXTRACELLULAR VESICLES (2012)
A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson Disease
Alexander Zimprich et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2011)
VPS35 Mutations in Parkinson Disease
Carles Vilarino-Gueell et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2011)
MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function
Elena Minones-Moyano et al.
HUMAN MOLECULAR GENETICS (2011)
α-Synuclein Sequesters Dnmt1 from the Nucleus A NOVEL MECHANISM FOR EPIGENETIC ALTERATIONS IN LEWY BODY DISEASES
Paula Desplats et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs
Tian Sheng Chen et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Treatment of Brain Inflammatory Diseases by Delivering Exosome Encapsulated Anti-inflammatory Drugs From the Nasal Region to the Brain
Xiaoying Zhuang et al.
MOLECULAR THERAPY (2011)
Parkinson's Disease and α-Synuclein Expression
Michael J. Devine et al.
MOVEMENT DISORDERS (2011)
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Lydia Alvarez-Erviti et al.
NATURE BIOTECHNOLOGY (2011)
Thermal- and Oxidative Stress Causes Enhanced Release of NKG2D Ligand-Bearing Immunosuppressive Exosomes in Leukemia/Lymphoma T and B Cells
Malin Hedlund et al.
PLOS ONE (2011)
Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II
Sean I. Savitz et al.
STROKE (2011)
NeurimmiRs: microRNAs in the neuroimmune interface
Hermona Soreq et al.
TRENDS IN MOLECULAR MEDICINE (2011)
The History of Parkinson's Disease: Early Clinical Descriptions and Neurological Therapies
Christopher G. Goetz
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2011)
MicroRNAs and deregulated gene expression networks in neurodegeneration
Kai-Christian Sonntag
BRAIN RESEARCH (2010)
Post-transcriptional Regulation of α-Synuclein Expression by mir-7 and mir-153
Epaminondas Doxakis
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Methylation Regulates Alpha-Synuclein Expression and Is Decreased in Parkinson's Disease Patients' Brains
Ahmad Jowaed et al.
JOURNAL OF NEUROSCIENCE (2010)
Molecular mechanism of multivesicular body biogenesis by ESCRT complexes
Thomas Wollert et al.
NATURE (2010)
Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury
Ruenn Chai Lai et al.
STEM CELL RESEARCH (2010)
Zeroing in on LRRK2-linked pathogenic mechanisms in Parkinson's disease
Saskia Biskup et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Lung cancer secreted microvesicles: Underappreciated modulators of microenvironment in expanding tumors
Marcin Wysoczynski et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Microenvironmental pH Is a Key Factor for Exosome Traffic in Tumor Cells
Isabella Parolini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Repression of α-synuclein expression and toxicity by microRNA-7
Eunsung Junn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Different methylation of the TNF-alpha promoter in cortex and substantia nigra: Implications for selective neuronal vulnerability
Heike C. Pieper et al.
NEUROBIOLOGY OF DISEASE (2008)
RNAi and RNAa - The Yin and Yang of RNAome
Peter Natesan Pushparaj et al.
BIOINFORMATION (2008)
A biochemical approach to identifying microRNA targets
Fedor V. Karginov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A microRNA feedback circuit in midbrain dopamine neurons
Jongpil Kim et al.
SCIENCE (2007)
Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusions
Justus C. Dachsel et al.
ACTA NEUROPATHOLOGICA (2007)
Aggregated α-synuclein mediates dopaminergic neurotoxicity in vivo
Magali Periquet et al.
JOURNAL OF NEUROSCIENCE (2007)
Parkinsonism, Lrrk2 G2019S, and tau neuropathology
A. Rajput et al.
NEUROLOGY (2006)
Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease
Masaaki Waragai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin
Ira E. Clark et al.
NATURE (2006)
Influence of heterozygosity for Parkin mutation on onset age in familial Parkinson disease : The GenePD study
Mei Sun et al.
ARCHIVES OF NEUROLOGY (2006)
LRRK2 in Parkinson's disease: protein domains and functional insights
Ignacio F. Mata et al.
TRENDS IN NEUROSCIENCES (2006)
The oxidation state of DJ-1 regulates its chaperone activity toward α-synuclein
WB Zhou et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Clinical heterogeneity of α-synuclein gene duplication in Parkinson's disease
K Nishioka et al.
ANNALS OF NEUROLOGY (2006)
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
AB West et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Alpha-synuclein and Parkinson's disease:: Implications from the screening of more than 1,900 patients
D Berg et al.
MOVEMENT DISORDERS (2005)
Regulation of α-synuclein expression by poly (ADP ribose) polymerase-1 (PARP-1) binding to the NACP-Rep1 polymorphic site upstream of the SNCA gene
O Chiba-Falek et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia
JJ Zarranz et al.
ANNALS OF NEUROLOGY (2004)
DJ-1 has a role in antioxidative stress to prevent cell death
T Taira et al.
EMBO REPORTS (2004)
Distribution, type, and origin of Parkin mutations:: Review and case studies
K Hedrich et al.
MOVEMENT DISORDERS (2004)
α-synuclein locus duplication as a cause of familial Parkinson's disease
MC Chartier-Harlin et al.
LANCET (2004)
Causal relation between α-synuclein gene duplication and familial Parkinson's disease
P Ibáñez et al.
LANCET (2004)
α-synuclein missense and multiplication mutations in autosomal dominant Parkinson's disease
AD Hope et al.
NEUROSCIENCE LETTERS (2004)
Parkinsonism among Gaucher disease carriers
O Goker-Alpan et al.
JOURNAL OF MEDICAL GENETICS (2004)
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
C Paisán-Ruíz et al.
NEURON (2004)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)
The neuromythology of Parkinson's disease
DB Calne et al.
PARKINSONISM & RELATED DISORDERS (2004)
The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization
RM Canet-Avilés et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
DJ-1 is a redox-dependent molecular chaperone that inhibits α-synuclein aggregate formation
S Shendelman et al.
PLOS BIOLOGY (2004)
Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson disease (PARK7)
R Hering et al.
HUMAN MUTATION (2004)
Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons
MS Goldberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
The role of pathogenic DJ-1 mutations in Parkinson's disease
PM Abou-Sleiman et al.
ANNALS OF NEUROLOGY (2003)
How much phenotypic variation can be attributed to parkin genotype?
E Lohmann et al.
ANNALS OF NEUROLOGY (2003)
Early-onset Parkinson's disease caused by a compound heterozygous DJ-1 mutation
S Hague et al.
ANNALS OF NEUROLOGY (2003)
Nuclear localization of α-synuclein and its interaction with histones
J Goers et al.
BIOCHEMISTRY (2003)
Exosome release is regulated by a calcium-dependent mechanism in K562 cells
A Savina et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease
T Foroud et al.
NEUROLOGY (2003)
Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism
V Bonifati et al.
SCIENCE (2003)
Linkage stratification and mutation analysis at the parkin locus identifies mutation positive Parkinson's disease families
WC Nichols et al.
JOURNAL OF MEDICAL GENETICS (2002)
Role of parkin mutations in 111 community-based patients with early-onset parkinsonism
M Kann et al.
ANNALS OF NEUROLOGY (2002)
Analysis of the coding and the 5′ flanking regions of the α-synuclein gene in patients with Parkinson's disease
P Pastor et al.
MOVEMENT DISORDERS (2001)
Lewy bodies and parkinsonism in families with parkin mutations
M Farrer et al.
ANNALS OF NEUROLOGY (2001)
Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations
BPC van de Warrenburg et al.
NEUROLOGY (2001)
Association between early-onset Parkinson's disease and mutations in the parkin gene
CB Lücking et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
